Mayumi Morimoto

ORCID: 0009-0002-2110-6341
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • T-cell and Retrovirus Studies
  • Cancer-related molecular mechanisms research
  • RNA regulation and disease
  • Herpesvirus Infections and Treatments
  • Animal Disease Management and Epidemiology
  • Diphtheria, Corynebacterium, and Tetanus
  • Botulinum Toxin and Related Neurological Disorders
  • Clostridium difficile and Clostridium perfringens research

Kyoto University
2023-2025

Abstract Background Spontaneous remission once a retroviral infection has been established does not occur and persists lifelong. Methods Stored blood samples obtained from simian T-cell leukemia virus type 1 (STLV-1)-infected Japanese macaque (JM; Macaca fuscata) mothers their offspring during long-term follow-up as well periodic health checkups were analyzed for proviral DNA levels, anti-STLV-1 antibody titer, sequence, viral transcription, clonality in peripheral mononuclear cells. Results...

10.1093/infdis/jiaf064 article EN The Journal of Infectious Diseases 2025-02-04

Primate T-cell leukemia virus type 1 (PTLV-1) is classified into a genus Deltaretrovirus that persists in infected primates and can lead to adult T cell inflammatory diseases. Unlike hepatitis viruses, it remains unclear whether PTLV-1 could cause occult infection, rare latent infection status characterized by detectable provirus without accompanying antibody responses. A longitudinal study was conducted characterize mother-to-child transmission of simian (STLV-1) Japanese monkeys (JMs)....

10.1093/infdis/jiaf120 article EN The Journal of Infectious Diseases 2025-03-04

A tetanus outbreak occurred during 2014-2015 in the rhesus macaques reared an open enclosure our facility. As soil of facility was suspected to be contaminated with Clostridium tetani spores, there a risk further occurring among macaques. To protect them from tetanus, toxoid vaccination recommended; however, vaccinated elderly animals might not effectively protected due insufficient humoral immune responses. Hence, we evaluated dynamics antibody responses all age groups two-dose at 1-year...

10.1538/expanim.23-0040 article EN EXPERIMENTAL ANIMALS 2023-01-01
Coming Soon ...